Concepedia

Natthakan Thongon

NT

Statistics

Publications

20

Citations

648

H-Index

15

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Trento

University of California, Los Angeles

Mahidol University

Istituti di Ricovero e Cura a Carattere Scientifico

Natthakan Thongon is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, oncology, and medicine.

Publications per year

2012–2024

20

Publications

20

Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function

Vito D’Agostino, Preet Lal, Barbara Mantelli et al. · Scientific Reports · 2015 · 90 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Irene Gañán‐Gómez, Hui Yang, Feiyang Ma et al. · Nature Medicine · 2022 · 81 citations · Full text

Medicine, Hematology, Pharmacology +17

A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3β Protein-dependent Activation of the Wnt/β-Catenin Signaling Pathway

Kanit Bhukhai, Kanoknetr Suksen, Narumol Bhummaphan et al. · Journal of Biological Chemistry · 2012 · 73 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Interfering with HuR–RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors

Leonardo Manzoni, Chiara Zucal, Danilo Di Maio et al. · Journal of Medicinal Chemistry · 2018 · 54 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA

Natthakan Thongon, Chiara Zucal, Vito D’Agostino et al. · Cancer & Metabolism · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 20